Sodium fluoride 12.3 MG/ML Oral Foam — RxCUI 831719
RxNorm drug concept · Semantic clinical drug
RxCUI 831719
Semantic clinical drug · SCD
● Current RxNorm concept 4 FDA products
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI831719
Official nameSodium fluoride 12.3 MG/ML Oral Foam
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assodium fluoride 1.23 % Oral Foam
FDA products mapped4
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How Sodium fluoride 12.3 MG/ML Oral Foam Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Sodium fluoride 12.3 MG/ML Oral Foam
RxCUI 831719 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Sodium fluoride
9873IN
-
Sodium fluoride
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Sodium fluoride Oral Foam
378213SCDF -
Sodium fluoride Oral Foam Product
1294866SCDG -
Sodium fluoride Oral Product
1159341SCDG -
Oral Foam
346284DF -
Oral Foam Product
1294709DFG -
Oral Product
1151131DFG
-
Sodium fluoride Oral Foam
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Sodium fluoride 12.3 MG/ML
330229SCDC
-
Sodium fluoride 12.3 MG/ML
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Sodium fluoride 12.3 MG/ML
SCDC · 330229 -
Sodium fluoride Oral Foam
SCDF · 378213 -
Sodium fluoride Oral Foam Product
SCDG · 1294866 -
Sodium fluoride Oral Product
SCDG · 1159341
📦 FDA Products & Package NDCs
4 products · 4 package NDCs
4 package NDCs map to RxCUI 831719 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 53045-0250-44 | 126 g in 1 BOTTLE (53045-250-44) | Ionite APF Foam | Dharma Research, Inc. | 2013-04-22 |
| 53045-0251-44 | 126 g in 1 BOTTLE (53045-251-44) | Ionite APF Foam | Dharma Research, inc. | 2013-04-22 |
| 53045-0252-44 | 126 g in 1 BOTTLE (53045-252-44) | Ionite APF Foam | Dharma Research, inc. | 2013-04-22 |
| 53045-0253-44 | 126 g in 1 BOTTLE (53045-253-44) | Ionite APF Foam | Dharma Research, inc. | 2013-04-22 |
Observed labelers:
Dharma Research, inc. (4)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.